We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.66%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$13.6M
(-0.5%)
Cap. Flow
-$24.4M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
459
New
46
Increased
82
Reduced
142
Closed
54
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVD
COVANCE INC.
CVD
|
+$22.9M |
| 2 |
Reinsurance Group of America
RGA
|
+$22.7M |
| 3 |
VeriSign
VRSN
|
+$22M |
| 4 |
Expedia Group
EXPE
|
+$20.9M |
| 5 |
Hormel Foods
HRL
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wynn Resorts
WYNN
|
+$30.4M |
| 2 |
L3Harris
LHX
|
+$26.8M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$23.4M |
| 4 |
Myriad Genetics
MYGN
|
+$18.4M |
| 5 |
US Bancorp
USB
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Industrials | 13.33% |
| 5 | Consumer Staples | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Exponent
EXPO
$3.42B
| $2.5M | 0.09% |
141,276
-404
| -0.3% | -$7.42K |
2013 Q4
3 quarters
|
|
152
US Physical Therapy
USPH
$1.28B
| $2.3M | 0.09% |
65,022
-220
| -0.3% | -$7.78K |
2013 Q2
5 quarters
|
|
153
American Coastal Insurance
ACIC
$525M
| $2.21M | 0.08% |
147,390
-510
| -0.3% | -$8.03K |
2014 Q2
1 quarter
|
|
154
DELISTED
Amicus Therapeutics
FOLD
| $2.19M | 0.08% |
367,370
-1,270
| -0.3% | -$6.65K |
2014 Q1
2 quarters
|
|
155
Universal Electronics
UEIC
$68.4M
| $2.18M | 0.08% |
44,113
+43,250
| +5,012% | +$2.23M |
2013 Q2
5 quarters
|
|
|
IGTE
156
DELISTED
IGATE CORPORATION
IGTE
| $2.15M | 0.08% |
58,607
-65,523
| -53% | -$2.44M |
2013 Q2
5 quarters
|
|
157
Maximus
MMS
$3.22B
| $2.09M | 0.08% |
52,040
-15,270
| -23% | -$632K |
2013 Q2
5 quarters
|
|
158
Evercore
EVR
$9.77B
| $1.94M | 0.07% |
41,288
-150
| -0.4% | -$7.77K |
2013 Q2
5 quarters
|
|
159
Standard Motor Products
SMP
$825M
| $1.8M | 0.07% |
52,326
-154
| -0.3% | -$5.95K |
2014 Q2
1 quarter
|
|
160
Agios Pharmaceuticals
AGIO
$1.87B
| $1.77M | 0.07% |
28,840
-60
| -0.2% | -$2.59K |
2014 Q2
1 quarter
|
|
|
DTSI
161
DELISTED
DTS, Inc.
DTSI
| $1.76M | 0.07% |
69,820
+67,730
| +3,241% | +$1.45M |
2014 Q2
1 quarter
|
|
|
NTRI
162
DELISTED
NutriSystem, Inc.
NTRI
| $1.74M | 0.06% |
113,230
-380
| -0.3% | -$6.31K |
2013 Q4
3 quarters
|
|
163
Lattice Semiconductor
LSCC
$14.7B
| $1.47M | 0.05% |
195,949
+1,599
| +0.8% | +$12K |
2014 Q2
1 quarter
|
|
|
CRZO
164
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1.47M | 0.05% |
27,264
+117
| +0.4% | +$7.15K |
2013 Q3
4 quarters
|
|
165
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.45M | 0.05% |
967
-4
| -0.4% | -$5.79K |
2013 Q2
5 quarters
|
|
166
Molina Healthcare
MOH
$10.8B
| $1.44M | 0.05% |
34,000
-30,620
| -47% | -$1.36M |
2014 Q2
1 quarter
|
|
167
Steris
STE
$21.7B
| $1.43M | 0.05% |
26,477
-12,070
| -31% | -$656K |
2013 Q2
5 quarters
|
|
168
DELISTED
Xoma
XOMA
| $1.41M | 0.05% |
16,764
-58
| -0.3% | -$4.95K |
2014 Q2
1 quarter
|
|
|
ISEE
169
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.23M | 0.05% |
+31,510
| New | +$1.24M |
2014 Q3
0 quarters
|
|
170
Huron Consulting
HURN
$2.78B
| $1.21M | 0.05% |
19,900
-70
| -0.4% | -$4.47K |
2014 Q1
2 quarters
|
|
|
RXII
171
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $1.14M | 0.04% |
552,160
-1,920
| -0.3% | -$3.95K |
2014 Q2
1 quarter
|
|
172
DELISTED
Immunogen Inc
IMGN
| $1.14M | 0.04% |
+107,270
| New | +$1.21M |
2014 Q3
0 quarters
|
|
173
Quaker Houghton
KWR
$2.7B
| $1.12M | 0.04% |
15,605
-50
| -0.3% | -$3.74K |
2013 Q3
4 quarters
|
|
174
Vanda Pharmaceuticals
VNDA
$244M
| $1.09M | 0.04% |
104,761
-350
| -0.3% | -$4.59K |
2013 Q4
3 quarters
|
|
|
SWC
175
DELISTED
Stillwater Mining Co
SWC
| $1.06M | 0.04% |
70,400
-240
| -0.3% | -$4.31K |
2014 Q2
1 quarter
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Smith Group Asset Management held 459 positions worth $2.7B, down 0.5% from $2.71B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Smith Group Asset Management's Q3 2014 filing shows 46 new, 82 increased, 142 reduced and 54 closed positions. Its largest new stake was COVANCE INC.: 269,945 shares worth $21.3M. The largest sale was Wynn Resorts, an estimated $30.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Smith Group Asset Management's largest Q3 2014 buy was COVANCE INC.: 269,945 shares worth $21.3M.
- Smith Group Asset Management added most to VeriSign in Q3 2014, an estimated $22M increase.
- Smith Group Asset Management's biggest Q3 2014 reduction was L3Harris, cutting an estimated $26.8M.
- Smith Group Asset Management fully exited Wynn Resorts in Q3 2014, selling an estimated $30.4M.
- Smith Group Asset Management's ten largest holdings make up 24% of its $2.7B portfolio in Q3 2014.
- Smith Group Asset Management opened 46 new positions and closed 54 in Q3 2014.
- Smith Group Asset Management's portfolio value fell 0.5% quarter-over-quarter to $2.7B.
Based on Smith Group Asset Management's 13F filing for Q3 2014, filed 28 Oct 2014.